STERIPATH® EVIDENCE

Independent Clinical Trial Results

Scholarly Articles

University of Houston College of Pharmacy
Journal of Clinical Microbiology
Published Date: October 2018

Peer-Reviewed: Conclusion: The findings support the routine use of ISDD during blood culture collection in the ED as a cost-beneficial strategy to reduce the clinical and economic impact of blood culture contamination in terms of microbiology, pharmacy and wider indirect hospital impact.

READ MORE
University of Nebraska Medical Center
University of Nebraska Medical Center
Clinical Infectious Diseases
Published Date: July 2017

Peer-Reviewed: Conclusion: Use of the ISDD was associated with a significant decrease in blood culture contamination in patients undergoing blood cultures in an Emergency Department setting.

READ MORE
Lee Health
Journal of Emergency Nursing
Published Date: April 2018

Peer-Reviewed: Conclusion: This unique collection system can reduce the risk of blood culture contamination significantly and is designed to augment, rather than replace, the standard phlebotomy protocol already in use in most health care settings.

READ MORE
Rush University Medical Center
IDWeek 2017

Conclusion: The use of the SP device in the ED over a 3-month period significantly reduced the rate of blood culture contamination from 4.3% to 0.6% while the rates of true bacteremia remain unchanged. The SP device represents a simple and effective method for reducing blood culture contamination.

READ MORE
San Antonio Military Medical Center
San Antonio Military Medical Center
Department of Defense Healthcare Quality and Safety Award Winner 2016

Conclusion: Data indicates use of SteriPath significantly reduces contamination rates. Approximately $5,000 per false positive result. BAMC has saved over $235,000 since September 2015 by utilizing SteriPath in Emergency Department.

READ MORE
San Antonio Military Medical Center
San Antonio Military Medical Center
Society for Healthcare Epidemiology of America 2017

Conclusion: Empiric vancomycin usage decreased after implementation of a molecular detection assay and diversion blood collection methods. While both pre and post-analytic methods decrease vancomycin use, greater de-escalation was best achieved through a combination of methods.

READ MORE
Beebe Healthcare
American Society for Microbiology, 2018

Conclusion: Use of the ISDD device led to a significant decrease in the BCC rate in all groups that participated in the trial: ED, ICU, and phlebotomy team. The contamination rate for specimens collected with the ISDD was 0.76%, which is a 73% reduction compared to the historical rate of 2.8%.

READ MORE
Medical University of South Carolina
Medical University of South Carolina
Institute for Healthcare Improvement 2017

Conclusion: ISDD use decreased FPBCs below 1% in a busy adult ED, well below the national benchmark of 3%, and the reduction in FPBC has been sustained for 20 months. Reducing FPBCs has led to reduced related costs and more efficient use of staff time, while helping to comply with national/international efforts to improve antibiotic stewardship and patient safety.

READ MORE
Medical University of South Carolina
Medical University of South Carolina
Institute for Healthcare Improvement 2016

Conclusion: The SteriPath device successfully reduced the number of FPBC over the 8-month trial period (average of 0.57% with vs 4.17% without). We suspect that vendor training lead to an increased focus on proper BC collection technique by all nursing personnel, resulting in a 50% decrease in FPBC rate for all adult ED BC (4.6% in FY2015 to 2.3% in FY2016).

READ MORE
Michael E. DeBakey VA Medical Center - Houston
Emergency Nurses Association, 2018

Conclusion: ER ISDD use resulted in a 83% decrease compared to UC (P=.01). ER study supported Leadership decision to implement the ISDD hospital-wide. High use areas [Acute care, Medical, Surgical, Prime Care, Phlebotomy and ER] began ISDD use October, 2017. As utilization of ISDD has increased, and with the conversion to the second generation ISDD, hospital-wide BCC rates have continued to decrease.

READ MORE
Evidence presented as a Green Belt Project 2016
VA - North Texas Health Care System
Green Belt Project 2016

Conclusion: A post-Steripath adoption blended (combined Steripath and standard method results) blood culture contamination rate of 1.7% at 50% compliance compared to a pre-Steripath implementation of 5.3%, representing a 69% reduction. Steripath enabled a 45% reduction in blood culture collection steps and an estimated savings of $332,500 over a five month period.

READ MORE

The evidence speaks for itself.

Let us share more.